Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study

Background. FOLFIRINOX chemotherapy is the current Dutch standard of care for locally advanced (LAPC) and metastatic pancreatic cancer (PDAC) patients with good performance status. The objective of this study was to evaluate real-world response rates and survival in advanced PDAC and to assess condi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of oncology 2022-07, Vol.2022, p.1-9
Hauptverfasser:	van der Sijde, Fleur, van Dam, Jacob L., Groot Koerkamp, Bas, Haberkorn, Brigitte C. M., Homs, Marjolein Y. V., Mathijssen, Daniëlle, Besselink, Marc G., Wilmink, Johanna W., van Eijck, Casper H. J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Cancer Cancer patients Cancer therapies Care and treatment Chemotherapy Cohort analysis Decision making Development and progression Hospitals Medical imaging Medical prognosis Metastasis Neutropenia Oncology, Experimental Pancreatic cancer Patient outcomes Patients Probability Radiation Response rates
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!